David C. Gale
No más puestos en curso
Perfil
David C.
Gale worked as Vice President-Research & Development at Artivion, Inc. and Intersect ENT, Inc. from 2007 to 2009.
He received his undergraduate and graduate degrees from The University of Manchester and a graduate degree from Auburn University.
He also earned a doctorate degree from The University of Alabama.
Antiguos cargos conocidos de David C. Gale.
| Empresas | Cargo | Fin |
|---|---|---|
| INTERSECT ENT, INC. | Director Técnico/Científico/I+D | 01/08/2009 |
| ARTIVION, INC. | Director Técnico/Científico/I+D | - |
Formación de David C. Gale.
| The University of Alabama | Doctorate Degree |
| Auburn University | Graduate Degree |
| The University of Manchester | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ARTIVION, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
- Bolsa de valores
- Insiders
- David C. Gale
